Merck Evolves Human Health Operating Structure to Support Portfolio Execution

robot
Abstract generation in progress

Merck is restructuring its Human Health organization into two business units: Oncology, and Specialty, Pharma & Infectious Diseases. This change aims to strengthen commercial execution for new product launches and leverage its diverse pipeline. Jannie Oosthuizen will lead Oncology and MSD International, while Brian Foard joins as president of Specialty, Pharma & Infectious Diseases, both reporting to the CEO.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin